This topic contains a solution. Click here to go to the answer

Author Question: Two technicians are discussing which lubricants are used in a limited-slip differential. Technician ... (Read 101 times)

ec501234

  • Hero Member
  • *****
  • Posts: 573
Two technicians are discussing which lubricants are used in a limited-slip differential. Technician A says to use SAE 80W-140. Technician B says that most vehicle manufacturers usually specify SAE 80W-90 be used with or without special limited-slip additives. Which technician is correct?
 
  A) Technician A only B) Technician B only
  C) Both technicians A and B D) Neither technician A nor B

Question 2

Technician A says that a semi-independent rear suspension is used with live rear axles. Technician B says that the semi-independent rear suspension is used only with non-drive rear axles. Which technician is correct?
 
  A) Technician A only B) Technician B only
  C) Both technicians A and B D) Neither technician A nor B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ilianabrrr

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

B

Answer to Question 2

B




ec501234

  • Member
  • Posts: 573
Reply 2 on: Jun 23, 2018
Wow, this really help


ultraflyy23

  • Member
  • Posts: 312
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library